Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
- PMID: 20550701
- PMCID: PMC2904285
- DOI: 10.1186/1465-9921-11-77
Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
Abstract
Introduction: The percentage of neutrophils in sputum are increased in COPD patients, and may therefore be a biomarker of airway inflammation. We studied the relationships between sputum neutrophils and FEV1, health status, exacerbation rates, systemic inflammation and emphysema, and long term variability at 1 year.
Methods: Sputum samples were obtained from 488 COPD patients within the ECLIPSE cohort. 359 samples were obtained at baseline, and 297 after 1 year. 168 subjects provided samples at both visits. Serum interleukin-6 (IL-6), IL-8, surfactant protein D and C-reactive protein levels were measured by immunoassays. Low-dose CT scans evaluated emphysema.
Results: Sputum neutrophil % increased with GOLD stage. There was a weak association between % sputum neutrophils and FEV1 % predicted (univariate r2 = 0.025 and 0.094 at baseline and year 1 respectively, p < 0.05 after multivariate regression). Similar weak but significant associations were observed between neutrophil % and health status measured using the St Georges Respiratory Questionairre. There were no associations between neutrophils and exacerbation rates or emphysema. Associations between sputum neutrophils and systemic biomarkers were non-significant or similarly weak. The mean change over 1 year in neutrophil % was an increase of 3.5%.
Conclusions: Sputum neutrophil measurements in COPD are associated weakly with FEV1 % predicted and health status. Sputum neutrophil measurements were dissociated from exacerbation rates, emphysema and systemic inflammation.
Trial registration: ClinicalTrials.gov NCT00292552.
Figures
Similar articles
-
Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.Respir Med. 2011 Dec;105(12):1853-60. doi: 10.1016/j.rmed.2011.07.002. Epub 2011 Jul 29. Respir Med. 2011. PMID: 21802933
-
A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality.Int J Chron Obstruct Pulmon Dis. 2018 Aug 22;13:2543-2550. doi: 10.2147/COPD.S165898. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30174423 Free PMC article.
-
Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.Radiology. 2020 Apr;295(1):218-226. doi: 10.1148/radiol.2020191429. Epub 2020 Feb 4. Radiology. 2020. PMID: 32013794 Free PMC article.
-
Neutrophilic Inflammation in the Pathogenesis of Chronic Obstructive Pulmonary Disease.COPD. 2018 Jun-Aug;15(4):392-404. doi: 10.1080/15412555.2018.1476475. Epub 2018 Jul 31. COPD. 2018. PMID: 30064276 Review.
-
Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.COPD. 2012 Dec;9(6):651-3. doi: 10.3109/15412555.2012.736317. COPD. 2012. PMID: 23244171 Review.
Cited by
-
Putative Systemic Biomarkers of Biomass Smoke-Induced Chronic Obstructive Pulmonary Disease among Women in a Rural South Indian Population.Dis Markers. 2018 Nov 22;2018:4949175. doi: 10.1155/2018/4949175. eCollection 2018. Dis Markers. 2018. PMID: 30595762 Free PMC article.
-
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1. Am J Respir Crit Care Med. 2011. PMID: 20889904 Free PMC article.
-
Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.Drugs. 2011 Oct 1;71(14):1821-37. doi: 10.2165/11595180-000000000-00000. Drugs. 2011. PMID: 21942975 Review.
-
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.Respir Res. 2014 Sep 4;15(1):103. doi: 10.1186/s12931-014-0103-4. Respir Res. 2014. PMID: 25183374 Free PMC article.
-
Extracellular matrix remodelling in COPD.Eur Respir Rev. 2020 Nov 18;29(158):190124. doi: 10.1183/16000617.0124-2019. Print 2020 Dec 31. Eur Respir Rev. 2020. PMID: 33208482 Free PMC article. Review.
References
-
- The Global Initiative for Chronic Obstructive Lung Disease (GOLD) http://www.goldcopd.com
-
- O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, Broberg P, Pierrou S, Lund J, Holgate ST, Davies DE, Delany DJ, Wilson SJ, Djukanovic R. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59:837–42. doi: 10.1136/thx.2003.019349. - DOI - PMC - PubMed
-
- Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153:530–4. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials